Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India

被引:27
作者
Modayil, Retty Rajan
Harugeri, Anand
Parthasarathi, Gurumurthy [1 ]
Ramesh, Madhan
Prasad, Rajendra [2 ]
Naik, Vasudeva [2 ]
Giriyapura, Vamadeva [3 ]
机构
[1] JSS Univ, Dept Clin Pharm, JSS Coll Pharm, Mysore 570015, Karnataka, India
[2] Krishna Rajendra Hosp, Mysore Med Coll, Mysore, Karnataka, India
[3] Karnataka State AIDS Prevent Soc, Bangaluru, India
关键词
pharmacovigilance; antiretroviral; adverse drug reaction; human immunodeficiency virus; HIV-INFECTED PATIENTS; RISK-FACTORS; ZIDOVUDINE; STAVUDINE; PREVALENCE; NEVIRAPINE; ANEMIA; HEPATOTOXICITY; LIPOATROPHY; NEUROPATHY;
D O I
10.1002/pds.1907
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To assess the nature, severity, predictability and preventability of adverse drug reactions (ADRs) and to identify risk factors for antiretroviral ADRs. Methods Enrolled ambulatory patients were intensively monitored for ADRs. Spontaneously reported ADRs by clinicians were also included. Predictability was assessed based on history of previous exposure to the drug or literature incidence of ADRs. Preventability was assessed using Schumock and Thornton criteria and severity was assessed using modified Hartwig and Siegel scale. Bivariate analysis and subsequently multivariate logistic regression were used to identify the risk factors for ADRs. Data from spontaneous reporting was assessed using Bayesian neural network method for possible ADR signals. Results Monitoring by active surveillance indentified 159 (52.82%) ADRs from 400 patients. One hundred and forty-two (47.17%) reactions were spontaneously reported. Anaemia and vomiting were the most commonly observed ADRs. The ADRs were severe in 10.9% of cases. A total of 88% ADRs were definitely/probably preventable. Use of Zidovudine+Lamivudine with Nevirapine or Efavirenz, CD4 <200 cells/mu l, female gender, tuberculosis and illiteracy were observed as risk factors for ADRs by bivariate analysis. Concurrent tuberculosis was the only influential risk factor for development of ADRs identified by multivariate logistic regression. Conclusion Prevalence of ADRs in intensively monitored patients was found to be 39.7%. Tuberculosis in HIV patients is an influential risk factor for occurrence of ADRs. With the increasing access to antiretrovirals in India, ADRs to antiretrovirals require monitoring and reporting. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:247 / 255
页数:9
相关论文
共 43 条
[1]  
BACHANI D, 2009, NACO NEWS, V5, P8
[2]  
Bogner JR, 2001, J ACQ IMMUN DEF SYND, V27, P237, DOI 10.1097/00126334-200107010-00004
[3]   Clinical outcomes of first antiretroviral regimen in HIV/hepatitis C virus co-infection [J].
Cooper, CL ;
Breau, C ;
LaRoche, A ;
Lee, C ;
Garber, G .
HIV MEDICINE, 2006, 7 (01) :32-37
[4]   Adverse drug reaction-related hospitalizations of nursing facility patients: A 4-year study [J].
Cooper, JW .
SOUTHERN MEDICAL JOURNAL, 1999, 92 (05) :485-490
[5]   Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy [J].
Curkendall, S. M. ;
Richardson, J. T. ;
Emons, M. F. ;
Fisher, A. E. ;
Everhard, F. .
HIV MEDICINE, 2007, 8 (08) :483-490
[6]   Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts [J].
De lazzari, E. ;
Leon, A. ;
Arnaiz, J. A. ;
Martinez, E. ;
Knobel, H. ;
Negredo, E. ;
Clotet, B. ;
Montaner, J. ;
Storfer, S. ;
Asenjo, M. A. ;
Mallolas, J. ;
Miro, J. M. ;
Gatell, J. M. .
HIV MEDICINE, 2008, 9 (04) :221-226
[7]   Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment [J].
de Maat, MMR ;
ter Heine, R ;
van Gorp, ECM ;
Mulder, JW ;
Mairuhu, ATA ;
Beijnen, JH .
AIDS, 2003, 17 (15) :2209-2214
[8]  
de Requena DG, 2002, AIDS, V16, P290, DOI 10.1097/00002030-200201250-00020
[9]  
Evans SJW, 2004, STEPHENS DETECTION N, P301
[10]   Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis [J].
Fagot, JP ;
Mockenhaupt, M ;
Bouwes-Bavinck, JN ;
Naldi, L ;
Viboud, C ;
Roujeau, JC .
AIDS, 2001, 15 (14) :1843-1848